Vaddi Krishna

Prelude Therapeutics Incorporated · CEO

Vaddi Krishna is listed in public filings as director, officer: CEO. This Vaddi Krishna insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Prelude Therapeutics Incorporated (PRLD). Investors use Vaddi Krishna's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
Prelude Therapeutics IncorporatedPRLD$467k675k sharesBuyMar 25, 2025$0.6925--